Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SHANNON NEVILLE WESTIN and LINGEGOWDA SELANERE MANGALA.
SHANNON NEVILLE WESTIN
Connection Strength
0.219
LINGEGOWDA SELANERE MANGALA
  1. EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer. Int J Mol Sci. 2024 Jan 20; 25(2).
    View in: PubMed
    Score: 0.059
  2. Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. Int J Mol Sci. 2023 Feb 15; 24(4).
    View in: PubMed
    Score: 0.055
  3. Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer. iScience. 2023 Feb 17; 26(2):106020.
    View in: PubMed
    Score: 0.055
  4. Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer. J Cancer Res Clin Oncol. 2022 Apr; 148(4):803-821.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.